SCHEMBL2959889

SCHEMBL2959889

COc1ccccc1-c1nc2c(C(=O)O)cccc2o1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 2/20 0.61
HTR3A P46098 2/20 0.59
KCNH2 Q12809 2/20 0.59
CYP3A4 P08684 1/20 0.58
IKBKB O14920 1/20 0.51
C1R P00736 1/20 0.50
TP53 P04637 1/20 0.49
MAPT P10636 1/20 0.49
GPR35 Q9HC97 3/20 0.49
VDR P11473 1/20 0.49
ALDH1A1 P00352 3/20 0.48
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48
HSD17B10 Q99714 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
PPARD Q03181 2/20 0.47
HTT P42858 1/20 0.46
ELANE P08246 1/20 0.45
MEN1 O00255 1/20 0.45
TSHR P16473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14367753 0.88 TOP2A (0.77) TOP2AHTR3AKCNH2CYP3A4IKBKB
SCHEMBL2964184 0.85 KDM4E (0.52) TOP2AHTR3AKCNH2CYP3A4TP53
SCHEMBL2957253 0.84 TOP2A (0.50) TOP2AHTR3AKCNH2CYP3A4TP53
SCHEMBL17931473 0.83 TOP2A (0.52) TOP2AHTR3AKCNH2CYP3A4TP53
SCHEMBL2964178 0.83 GPR35 (0.48) TOP2AHTR3AKCNH2CYP3A4IKBKB
SCHEMBL5619661 0.83 PTGER1 (0.56) TOP2AHTR3AKCNH2
SCHEMBL3401507 0.82 TOP2A (0.58) TOP2AIKBKBTP53MAPTALDH1A1
SCHEMBL2959863 0.81 TOP2A (0.70) TOP2AHTR3AKCNH2CYP3A4ALDH1A1
SCHEMBL121763 0.80 TOP2A (0.55) TOP2AIKBKBC1RTP53MAPT
SCHEMBL2962341 0.80 TOP2A (0.55) TOP2AHTR3AKCNH2CYP3A4C1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781430-B2 Benzoxazole carboxamides for treating CINV and IBS-D ALBANY MOLECULAR RESEARCH, INC. (US) 2010-08-24 US disclosed
US-20080108609-A1 Benzoxazole Carboxamides For Treating CINV and IBS-D AMR TECHNOLOGY, INC. (US) 2008-05-08 US disclosed
US-7307094-B2 Benzoxazole carboxamides for treating CINV and IBS-D AMR TECHNOLOGY, INC. (US) 2007-12-11 US disclosed
EP-1853597-A1 BENZOXAZOLE CARBOXAMIDES FOR TREATING CINV AND IBS-D AMR Technology, Inc. (US) 2007-11-14 EP disclosed
US-7294643-B2 UK-1 analogues: methods of preparation and use BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2007-11-13 US disclosed
US-7294643-B2 UK-1 analogues: methods of preparation and use BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2007-11-13 US disclosed
WO-2006089100-A1 BENZOXAZOLE CARBOXAMIDES FOR TREATING CINV AND IBS-D AMR TECHNOLOGY, INC. (US) 2006-08-24 WO disclosed
US-20060183769-A1 Benzoxazole carboxamides for treating CINV and IBS-D AMR TECHNOLOGY, INC. (US) 2006-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108609-A1 Benzoxazole Carboxamides For Treating CINV and IBS-D HTR3E, BRS3, HTR3A TOP2A 1421/4885HTR3A 3/4885KCNH2 1078/4885
US-20060183769-A1 Benzoxazole carboxamides for treating CINV and IBS-D HTR3E, BRS3, HTR3A TOP2A 1421/4885HTR3A 3/4885KCNH2 1078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.